Welcome to “Fly Insider,” The Fly’s weekly recap of notable insider stock transactions.
NOTABLE INSIDER PURCHASES: Significant insider purchases reported in the prior week from October 16 through October 20 include:
- Beneficial owner of Day One Biopharmaceuticals (DAWN) AI Day1 purchased 1,475,454 shares of company stock at $10.15 per share for a total transaction amount of $14,978,219
- Holder of Scholar Rock Holding (SRRK) Invus Public purchased 2,199,931 shares of company stock at $6.86 per share for a total transaction amount of $15,086,687
- Beneficial Owner of Tango Therapeutics (TNGX) Boxer Capital purchased 1,250,000 shares of company stock at $6.98 per share for a total transaction amount of $8,722,500
- Beneficial Owner of Frontier Communications (FYBR) purchased 150,000 shares of company stock at $18.93 per share for a total transaction amount of $2,838,930
NOTABLE INSIDER SALES: Significant insider sales reported in the prior week from October 16 through October 20 include:
- COO of ABM Industries (ABM) Rene Jacobsen sold 6,341 shares of company stock at $44 per share for a total transaction amount of $279,001
- President of Core & Main (CNM) Bradford Cowles sold 50,000 shares of company stock at $31.94 per share for a total transaction amount of $1,596,780
- VP of Jabil (JBL) Daryn Smith sold 1,937 shares of company stock at $137.24 per share for a total transaction amount of $265,839
- VP of VMware (VMW) Jean Pierre Brulard sold 5,779 shares of company stock at $178.29 per share for a total transaction amount of $1,030,338.
NOTABLE PRICE MOVEMENT AFTER INSIDER TRANSACTION: Shares of Tango Therapeutics moved up approximately 22% after Boxer Capital purchased 1.25M shares of company stock at $6.98 per share, while shares of VMware fell over 20% after VP Jean Pierre Brulard sold 5,779 shares of company stock at $178.29 per share.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on DAWN:
- Avadel Pharmaceuticals added to Conviction List at Needham
- Day One Biopharmaceuticals files automatic mixed securities shelf
- Day One Announces Updated FIREFLY-1 Data for Tovorafenib and Completion of Rolling NDA Submission to FDA for Relapsed or Progressive Pediatric Low-Grade Glioma (pLGG)
- Day One takes ‘another step toward defeating bear thesis,’ says H.C. Wainwright
- Day One tovorafenib NDA filing completed sooner-than-expected, says Oppenheimer